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physician, without knowing that they are pregnant or worse, they become pregnant between
the time of the office visit and the appointment
for the radiological examination. These situations
can be concerning for the patient and the physician. In order for the physician to interpret the
various forms of exposure measurement,
Table 1 lists the various nomenclatures for radiation exposures, so that the reader will be able
to understand radiation exposures in the terms
with which they may be familiar.
Pulmonologists are fortunate with regard to
the specific studies they request to provide clinical care because most of the diagnostic tests
do not directly expose the uterus (embryo) or
ovary. Radiography of the chest, head, neck,
teeth, or extremity exposes the embryo or ovary
to miniscule (insignificant) exposures of radiation. In some instances, there is no exposure
at all.
The pulmonologists may infrequently order
diagnostic studies that exposes the abdomen or
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Almost every practicing physician is aware that
the use of diagnostic radiological techniques
and radiation therapy using ionizing radiation
has increased substantially over the past 30
years.1 In 1980, the US population received
20% of their exposure to ionizing radiation from
medical care. The National Council on Radiation
Protection and Measurements (NCRP) No. 160
(2009) reported that almost 50% of the population’s radiation exposure came from medical
care. Unfortunately, this increased exposure has
been presented in the newspapers, television,
and Internet, and in many instances, the risks
of birth defects, miscarriage, and cancer have
been exaggerated and the benefits ignored. It
is important for physicians to become as knowledgeable about the risks of ionizing radiation as
they are about its benefits. Although pulmonologists do not concentrate their practice on pregnant women or women of reproductive age,
these patients are a part of their practice. An
important concern is that many women visit their
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Table 1
Ionizing radiation exposure terminology
Rad/Rem

Millirad/Millirem

Gray (Gy), Milligray (mGy)

Sievert (Sv), Millisievert (mSv)

0.001
0.01
0.1
1
10
100

1
10
100
1000
10,000
100,000

0.01 mGy
0.1 mGy
1 mGy
0.01 Gy
0.1 Gy
1 Gy

0.01 mSv
0.1 mSv
1 mSv
0.01 Sv
0.1 Sv
1 Sv

The units of rad and rem and the gray and sievert are identical for exposures of low energy transfer radiation, such as
x-rays, g-rays, b-rays, and protons. These forms of radiation have a relative biological effectiveness (RBE) rated at one.
Exposures to a-rays and neutrons have a biologic effectiveness greater than one. The rem and the sievert take into consideration the RBE of the radiation. For clinicians, the RBE is infrequently relevant because most radiological procedures use
radiation with an RBE of 1 so the gray and sievert exposures will be identical.

pelvis to radiation but they should be aware of
other studies that could have been ordered by
other providers. The vast majority of diagnostic
studies exposing the abdomen or pelvis to radiation also expose the embryo or ovary to less than
10 rad (0.1 Gy).

THE REPRODUCTIVE AND DEVELOPMENTAL
RISKS OF EXPOSURES OF IONIZING
RADIATION TO PREGNANT OR POTENTIALLY
PREGNANT WOMEN
The reproductive and developmental risks of in
utero exposures to ionizing radiation are listed
below (Tables 2 and 3).
1. Birth defects, mental retardation, other neurobehavioral effects, growth retardation, and embryonic death (miscarriage) are deterministic effects
(threshold effects). These effects have a no
observed adverse effect level (NOAEL). Almost
all diagnostic radiological procedures provide
exposures that are below the NOAEL for these
developmental effects. Diagnostic radiological
studies rarely exceed 10-rad (0.1 Gy) exposure,
whereas the threshold for congenital malformations or miscarriage is more than 20 rad
(0.2 Gy) (see Table 2).
2. In order for the embryo to be deleteriously
affected by ionizing radiation when the mother
is exposed to a diagnostic study, the embryo
has to be exposed above the NOAEL to
increase the risk of deterministic effects. This
scenario rarely happens when pregnant women
undergo radiographic studies of the head,
neck, chest, or extremities.
3. During the preimplantation and preorganogenesis stages of embryonic development, the
embryo is least likely to be malformed by the
effects of ionizing radiation because the cells
of the very young embryo are omnipotent and

can replace adjacent cells that have been deleteriously affected. This early period of development has been designated as “the all or none
period.”
4. Protraction and fractionation of exposures of
ionizing radiation to the embryo decrease the
magnitude of the deleterious effects of deterministic effects. The more protracted or fractionated the radiation, the lower the risk
because the threshold increases.
5. The increased risk of cancer following high level
of exposures to ionizing radiation in adult populations has been demonstrated in the survivors
of atomic bomb. Radiation-induced carcinogenesis is assumed to be a stochastic effect
(nonthreshold effect), so that there is theoretically a risk at low-level exposures. While there
is no question that high-level exposures of
ionizing radiation can increase the risk of
cancer, the magnitude of cancer risk from
embryonic exposures following diagnostic
radiological procedures is controversial. Recent
publications and analyses indicate that the risk
is lower for the irradiated embryo than the irradiated child, which surprised many scientists
interested in this subject (Tables 4e6).2

EVALUATING THE RISKS OF RADIATION
EXPOSURE TO THE DEVELOPING EMBRYO
When evaluating the risks of ionizing radiation, the
physician is faced with several different clinical
situations:

Situation 1
The pulmonologists are fortunate because the
radiological tests that would be ordered for their
patients do not expose the embryo directly, and
therefore, the embryo does not receive an exposure that would increase the risk for birth defects,
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Table 2
Radiation effects at different stages of gestation
Stage, Gestation Weeks

Effect

First and second week after last
menstrual period (before conception)

First 2 wk after the first day of the last menstrual period.
This is preconception radiation. Mother has not yet
ovulated
Minimum acute lethal dose in humans (from animal
studies). Approximately 0.15e0.20 Gy. Most sensitive
period for the induction of embryonic death. No
increase in risk of malformations in surviving fetuses. All
or none stage
Minimum lethal dose (from animal studies). At 18 d
postconception, 0.25 Gy (25 rad). After 50 days
postconception, >0.50 Gy (50 rad)
Embryo is vulnerable to the induction of major
malformations. Threshold for malformations is >0.2e0.5
Gy, depending on the malformation
Minimum dose for growth retardation. At 18e36 d,
0.20e0.50 Gy (20e50 rad). At 36e110 d, 0.25e0.50 Gy
(25e50 rad) But the induced growth retardation during
this period is not as severe as during midgestation (8e15
wk) from similar exposures and is more recuperable19
Most sensitive period for irreversible whole body growth
retardation, microcephaly, and severe mental
retardation. Threshold for severe metal retardation is
0.35e0.50 Gy (35e50 rad). Miller20 believes the
threshold is >0.5 Gy. Decrease in IQ can occur at lower
exposures
Higher exposures can produce growth retardation and
decreased brain size and intellect, although the effects
are not as severe as those from similar exposures during
midgestation. There is no documented risk for major
anatomic malformations. Minimum lethal dose
threshold for mental retardation (from animal studies) is
from 15 wk to term >1.5 Gy (150 rad), but decrease in IQ
can occur at lower exposures

Third and fourth week of gestation
(first 2 wk postconception)

Fourth to eighth week of gestation
(second to sixth week postconception)

Eighth to fifteenth week of gestation

Sixteenth week to term of gestation

There is no evidence that radiation exposure in the diagnostic ranges (<0.10 Gy, <10 rad) is associated with measurably
increased incidence of congenital malformation, stillbirth, miscarriage, growth retardation, or mental retardation.

miscarriage, growth retardation, mental retardation, or neural behavioral effects (Table 7).
Table 7 lists the frequently used diagnostic radiological and radionuclide tests. None of the tests
exceed exposures of 10 rad (0.1 Gy or 100 mGy)
except for radiation therapy or extensive fluoroscopy to the abdomen or pelvis.
Although most diagnostic radiological studies of
the abdomen or pelvis do not expose the embryo
to more than 10 rad (0.10 Gy), the family is upset
because they are aware that the embryo was directly
exposed. Under these circumstances it may be
necessary to request the health physicist to calculate the actual exposure to allay the family’s concern.

Situation 2
The pregnant patient presents with clinical symptoms that need to be evaluated. What is the

appropriate use of diagnostic radiological procedures that may expose the embryo or fetus to
ionizing radiation?
A pregnant or possibly pregnant woman complaining of chest symptoms that cannot be attributed to pregnancy deserves the appropriate
studies to diagnose and treat the clinical problems, including radiological studies. Furthermore,
these studies should not be relegated to one
portion of the menstrual cycle if the patient has
not yet missed her period. The studies should
be performed at the time they are clinically indicated whether or not the patient is in the first or
second half of the menstrual cycle. During the
second half of the menstrual cycle the pregnancy
test result may be negative even though the
patient is pregnant. This situation should be
explained to the patient and the family.
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Table 3
Reproductive risks per million recognized pregnancies
Reproductive Risks

Frequency

Immunologically and clinically diagnosed spontaneous abortions per million
conceptions (<20% has lethal malformations or chromosomal abnormalities that
cause abortion before the first month of gestation)
Clinically recognized spontaneous abortions per million clinically recognized
pregnancies. Spontaneous abortion after the first missed menstrual period
Genetic diseases per million births
Multifactorial or polygenic genetic environmental interactions)
Dominantly inherited disease
Autosomal and sex-linked genetic disease
Cytogenetic (chromosomal abnormalities)
New mutations in the developing ova or sperm before conception
Major malformations (genetic, unknown, environmental)
Prematurity (Ireland 55,000; United States 124,000)
Fetal growth retardation
Stillbirths (>20 wk)
Infertility

350,000

150,000
110,000
90,000
10,000
1200
5000
3000
30,000
69,000
30,000
4000e20,900
7% of couples

Data from Brent RL. Utilization of developmental basic science principles in the evaluation of reproductive risks from preand postconception environmental radiation exposures. Teratology 1999;59:182e204.

Situation 3
A patient has completed a diagnostic procedure
that has exposed her uterus to ionizing radiation.
Her pregnancy test result was negative. She
believes she was pregnant at the time of the procedure. What is your response to this situation?
Explain that you would have proceeded with the
necessary radiological diagnostic test whether the
patient was pregnant or not because diagnostic

studies that are indicated in the patient have to
take priority over the possible risk to her embryo;
however, almost 100% of diagnostic studies do
not increase the risks to the embryo (see
Table 1). Second, she must have been very early
in her pregnancy because her pregnancy test
result was negative. At this time, obtain the calculated dose to the embryo and determine her stage
of pregnancy. If the dose is less than 10 rad (0.1
Gy; 0.1 Sv), you can inform the patient that her

Table 4
Risk of 10-rad (0.1 Gy) exposure to the embryo

Risks

Background Incidence
(per 106 pregnancies)

Additional Risk of 10-rad
(0.1 Gy) Exposure

350,000

0

Very early pregnancy loss, before the
first missed period
Spontaneous abortion in a known
pregnant women
Major congenital malformations
Severe mental retardation
Childhood leukemia per year

150,000

0

30,000
5000
40

Early- or late-onset genetic disease
Prematurity
Growth retardation
Stillbirth
Infertility

100,000
69,000
30,000
20e2000
7% of couples

0
0
Very low increased risk, and possibly
no measurably identifiable
increased risk
Very low risk in next generation
0
0
0
0
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Table 5
Follow-up of adults with solid cancers in Hiroshima and Nagasaki, who were in utero at the time of
detonation of the atomic bombs in 1945

Dose in Sv (rad)

No. of Patients

No. of Cancers

Person-Years

Percentage with
Solid Cancers

<0.005 (<0.5)
0.005e<0.1 (0.5e10.0)
0.1e<0.2 (10e<20)
0.2e<0.5 (20e<50)
0.5e<1.0 (50e<100)
>1
Total

1547
435
168
172
92
48
2452

54
16
6
8
7
3
94

49,326
14,005
5041
5496
2771
1404
94

3.5
3.7
3.6
4.6
7.6
6.2
3.5

Data from Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as
young children. J Natl Cancer Inst 2008;100:428e36.

risks for birth defects and miscarriage have not
been increased. In fact, the threshold for these
effects is 20 rad (0.2 Gy) at the most sensitive
stage of embryonic development (see Table 2).
Of course, you are obligated to tell the patient
that every healthy woman is at risk for the background incidence of birth defects and miscarriage,
which is 3% for birth defects and 15% for miscarriage (see Table 3).

Situation 4
A woman delivers a baby with serious birth
defects. On her first postpartum visit, she recalls
that she had a diagnostic radiological study early
in her pregnancy. What is your response when
she asks you whether the baby’s malformation
could be caused by the radiation exposure?
In most instances, the nature of the clinical malformations can rule out radiation teratogenesis
(microcephaly, mental retardation, and fetal
growth retardation). In such a case, a clinical

teratologist or radiation embryologist could be of
assistance. On the other hand, if the exposure is
less than 10 rad (0.1 Gy), it would not be scientifically supportable to indicate that the radiation
exposure was the cause of the malformation. The
threshold for malformations is 20 rad (0.2 Gy)
(see Table 2). The dose, timing, and nature of
the malformation are considered in this analysis.
To appropriately and more completely respond
to these questions, the physician should rely on
the extensive amount of available information on
the effects of radiation on embryos. In fact, there
is no environmental hazard that has been more
extensively studied or on which more information
is available (see Tables 2 and 4).3e12

RADIATION RISKS TO THE EMBRYO
An acute exposure to ionizing radiation more than
50 rad represents a significant risk to the embryo,
regardless of the stage of gestation.6e9,12,13 The

Table 6
Follow-up of adults with solid cancers in Hiroshima and Nagasaki, who were children at the time of
detonation of the atomic bombs in 1945
Dose in Sv (rad)

No. of Patients

No. of Cancers

Person-Years

Percentage of Cancers

<0.005 (<0.5)
0.005e<0.1 (0.5e10)
0.1e<0.2 (10e<20)
0.2e<0.5 (20e<50)
0.5e<1.0 (50e<100)
>1
Total

8549
4528
853
859
325
274
15,388

318
173
38
51
21
48
649

247,744
134,621
25,802
25,722
9522
7620
451,031

3.7
3.8
4.4
5.9
6.5
17.5
4.2

Data from Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as
young children. J Natl Cancer Inst 2008;100:428e36.
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Table 7
Typical doses for selected medical procedures

Type

Description

Embryo/Fetal Dose
Range (mGy)

Gonadal Dose (Ovaries,
Testes) (mGy)

Radiography
Radiography
Radiography
Radiography
Radiography
Radiography
Radiography
Radiography
Radiography
CT
CT
CT
Chest Fluoroscopy
IR fluoroscopy
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine
Nuclear Medicine

Skull
Chest
Thoracic spine
Mammography
Barium meal
Pelvis
Lumbar spine
Abdomen
Barium enema
Chest/CTPA
Abdomen
Pelvis
Chest
Abdominal fluoroscopy
Lung ventilation
Lung perfusion
White cell scan
Renal scan
Bone scan
Cerebral blood flow
PET
Myocardial perfusion
Therapy

<0.01
<0.01
<0.01
<0.01
0.1e1.1
0.1e1.1
1e2
1e3
7e8
0.1e1
4e16
10e32
<0.1 mGy/min
6 mGy/min
0.1-0.3
0.1e0.4
0.7e1.4
3e7
4.5e7.0
5e10
8e16
16.7e22.2
>50

<0.01, <0.01
<0.01, <0.01
<0.01, <0.01
<0.01, <0.01
1.2, 4.6
4.3, 0.6
2.2, 0.4
16, 3.4
0.08, <0.01
8.0, 0.7
23, 1.7

0.13e0.5, 0.13e0.5
0.06e0.27, 0.04e0.16
1.0e2.0, 0.7e1.4
2.7e4.0, 1.8e2.7
3.7e7.3, 1.3e2.7
5.6e11.1, 4.4e8.8
9.3e12.4, 2.7e3.6
31, 19

Abbreviations: CT, computed tomography; CTPA, CT pulmonary angiography; PET, positron emission tomography.

threshold dose for low energy transfer ionizing radiation that results in an increase in malformations is
approximately 20 rad (0.2 Gy) (see Table 2).
Although congenital malformations are unlikely to
be produced by radiation during the first 14 days
of human development, there would be a substantial risk of embryonic loss if the dose is high. From
approximately the 18th day to the 40th day postconception, the embryo would be at risk for an
increased frequency of anatomic malformations if
the radiation exposure exceeds 20 to 25 rad
(0.20e0.25 Gy). Until about the 15th week, the
embryo has an increased susceptibility to central
nervous system (CNS) effects, major CNS malformations early in gestation, and mental retardation
in midgestation. Of course, with very high doses,
in the hundreds of rads, mental retardation can
occur in the later part of gestation. Although it is
true that the embryo is vulnerable to the deleterious
effects of these midrange exposures of ionizing
radiation, the measurable effects fall off rapidly as
the exposure approaches the usual levels that the

embryo receives from diagnostic radiological
procedures (<10 rad [0.1 Gy]). The threshold of 20
rad (0.2 Gy) at the most vulnerable stage of development (20e25 days postconception) is increased
by protraction of the radiation exposure. If a pregnant woman had a series of radiographic analyses
over a period of 3 to 4 days with a total exposure of
15 rad (0.15 Gy), there would be no increased risk
for any of the developmental threshold (deterministic) effects.6,12,13 The recommendations of most
radiation embryologists indicate that exposures in
the diagnostic range do not increase the risk of birth
defects or miscarriage.6,8,9,12 Table 4 compares
the spontaneous risks facing an embryo at conception and the risks from a low-level exposure of
ionizing radiation (10 rad; 100 mGy; 10,000 mrad).
Therefore, the hazards of exposures in the range
of diagnostic radiological studies (20e10,000
mrad [0.2 mGye0.1 Gy]) present an extremely
low risk to the embryo when compared with the
spontaneous mishaps that can befall human
embryos (see Tables 3 and 4). Approximately
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30% to 40% of human embryos abort spontaneously (many abort before the first missed
menstrual period) (see Table 3). Human infants
have a 3% major malformation rate at term that
increases to approximately 6% to 8% once all
minor malformations are recorded. Although
doses from 1 to 3 rad (0.01e0.03 Gy) can produce
cellular effects and diagnostic radiation exposure
during pregnancy has been associated with malignancy in childhood, the maximum theoretic risk to
human embryos exposed to doses of 10 rad (0.1
Gy) or less is extremely small. When the data
and risks are explained to the patient, the family
with a wanted pregnancy invariably continues
with the pregnancy.
A frequent difficulty is that the risks from diagnostic radiation exposure are evaluated outside
the context of the significant normal risks of pregnancy. Furthermore, many physicians approach
the evaluation of diagnostic radiation exposure
with either of the 2 extremes: a cavalier attitude
or panic. The usual procedures in clinical medicine
are ignored, and an opinion based on meager
information is given to the patient. Frequently,
this attitude reflects the physician’s bias about
radiation effects or his or her ignorance of radiation
biology. We have patient records in our files of
scores of patients who were not properly evaluated but were advised to have an abortion
following radiation exposure. The following case
history is an example.

CASE REPORT
A 33-year-old woman was diagnosed with breast
cancer and radiation therapy for the breast was
initiated. Four weeks into her therapy, it was
discovered that she was 11 weeks pregnant. The
oncologist, radiation therapist, and surgeon
encouraged the patient and her family to abort
the pregnancy. She already had received 3800
rad (3.8 Gy) to the breast. The family asked for
another opinion, and our counseling service was
contacted. The health physicist at the consultee
institution had calculated that the fetus had
received 50 rad (0.5 Gy) over a period of almost
4 weeks. On each day of therapy the fetus had
received 0.9 rad (0.009 Gy). Each week the fetus
had 2 days without being exposed. The patient’s
physicians still suggested a therapeutic abortion
but with less certainty. They asked me what
I would tell her. I said, “I would not tell her anything.
I wanted to talk with her.”
When we were able to talk, she immediately
asked what should she do. I responded, “Do you
have any questions?” She asked, “Could my baby
be malformed?” I told her that 3% of babies are

malformed and this is the background incidence.
But in her case, the fetus’s risks for major birth
defects were not increased for 2 reasons: (1) the
radiation therapy was initiated in the seventh
week after all the organs had formed and (2) more
important, the dose each day was too low to
produce malformations at any stage of pregnancy.
Then she asked whether her baby could be
severely mentally retarded. I answered her in the
negative. But I also had to tell her that 1 in 200 children is born mentally retarded. She then asked
whether the baby could be growth retarded. I responded that 4% of newborns are growth retarded
but that the radiation exposure would not cause
significant growth retardation. Finally, she asked,
“Could my baby be normal?” I said, “Yes.”
The mother decided against abortion and delivered a 3-kg baby boy who was physically normal
and has been developing, according to the
mother, very normally.

EVALUATING THE PATIENT
Case histories are transmitted to our laboratory
frequently. In 2008, we had 2,200,000 hits on
our pregnancy Web site of the Health Physics
Society, “Ask the Expert.” There were 760,000
downloads and 1646 direct consultations. In
most instances, the dose to the embryo is less
than 10 rad (0.1 Gy) and is frequently more than
1 rad (0.01 Gy). Our experience has taught us
that there are many variables involved in radiation
exposure to a pregnant or potentially pregnant
woman. Therefore, there is no routine or predetermined advice that can be given in this situation.
However, if the physician takes a systematic
approach for the evaluation of the possible effects
of radiation exposure, he or she can help the
patient make an informed decision about
continuing the pregnancy. This systematic evaluation can begin only when the following information has been obtained:










Stage of pregnancy at the time of exposure
Menstrual history
Previous pregnancy history
Family history of congenital malformations
and miscarriages
Other potentially harmful environmental
factors during the pregnancy
Ages of the mother and father
Type of radiation study and dates and
number of studies performed
Calculation of the embryonic exposure by a
medical physicist or competent radiologist
Status of the pregnancy, wanted or
unwanted.

39

40

Brent
The evaluation should be concluded, with both
patient and counselor arriving at a decision. The
physician should provide a summary in the
medical record, stating that the patient has been
informed that every pregnancy has a significant
risk of problems and that the decision to continue
the pregnancy does not mean that the counselor is
guaranteeing the outcome of the pregnancy. The
use of amniocentesis and ultrasonography to evaluate the fetus is an individual decision to be made
in each pregnancy.
Each consultation should include the following
statement. “If you are healthy, young (under 35)
and have no personal or family history of reproductive or fetal developmental problems, then
you began this pregnancy with a risk of 3% for
birth defects and 15% for miscarriage. These are
background risks faced by all pregnant women.
Good luck with this pregnancy and keep in touch.”

THE CARCINOGENIC EFFECTS OF RADIATION
The carcinogenic risks of in utero radiation is an
important topic that cannot be addressed
adequately in this article. In 1956, Stewart and
colleagues13 published the results of their casecontrol studies indicating the diagnostic radiation
from pelvimetry was associated with a 50%
increased risk of childhood leukemia (see Table 4).
The risk of childhood leukemia could thus increase
from 40 cases per million to 60 cases per million in
the population of radiation-exposed fetuses. This
issue has been a very controversial subject.12e17
Preston and colleagues2 presented data from the
in utero population of the atomic bomb survivors,
and the data indicated that the embryo was less
vulnerable to the oncogenic effects of ionizing radiation than a child. It seems that the embryo is much
less vulnerable to the oncogenic effects of radiation
than previous investigators have believed. Patients
can be told that the fetal risk is extremely small to
be measured and also because a large exposed
population would be necessary (see Tables 3e5).
Even if one accepts the controversy that the embryo
is more vulnerable to the carcinogenic effects of
radiation than a child, the risk at these low-level
exposures is extremely smaller than spontaneous
risks.1 Furthermore, other studies indicate that
Stewart and colleagues’13 estimate of the risk
involved is exaggerated.10,11,15e17

DIAGNOSTIC OR THERAPEUTIC
ABDOMINAL RADIATION IN WOMEN
OF REPRODUCTIVE AGE
In women of reproductive age, it is important for
the patient and the physician to be aware of the

pregnancy status of the patient before performing
any type of radiological procedure in which the
ovaries or uterus is exposed. If the embryonic
exposure is 10 rad (0.1 Gy) or less, the radiation
risk to the embryo are very small when compared
with the spontaneous risks (see Tables 2e5). Even
if the exposure is 10 rad (0.1 Gy), this exposure is
far from the threshold or no-effect dose of 20 rad
(0.2 Gy). The patient will accept this information if
it is offered as part of the preparation for the radiological studies at a time when both the physician
and patient are aware that a pregnancy exists or
may exist. The pregnancy status of the patient
should be determined and noted.
Because the risks of 10-rad (0.1 Gy) fetal irradiation are so small, the immediate medical care of
the mother should take priority over the risks of
diagnostic radiation exposure to the embryo.
Radiological studies that are essential for optimal
medical care of the mother and evaluation of
medical problems that need to be diagnosed or
treated should not be postponed. Elective procedures such as employment examinations or
follow-up examinations, once a diagnosis has
been made, need not be performed on a pregnant
woman even though the risk to the embryo is very
small. If other procedures (eg, magnetic resonance imaging or ultrasonography) can provide
adequate information without exposing the
embryo to ionizing radiation, then they should be
used. Naturally, there is a period when the patient
is pregnant but the pregnancy test result is negative and the menstrual history is of little use.
However, the risks of exposure to 10 rad (0.1 Gy)
or less are extremely small during this period of
gestation (all or none period,4 first 2 weeks). The
patient will benefit from knowing that the diagnostic study was indicated and should be performed even though she may be pregnant.

SCHEDULING THE EXAMINATION
When elective radiological studies need to be
scheduled, it is difficult to know whether to
schedule them during the first half of the menstrual
cycle just before ovulation or during the second
half of the menstrual cycle, when most women
are not pregnant. The genetic risk of diagnostic
exposures to the oocyte or the embryopathic
effects on the preimplanted embryo are extremely
small, and there are no data available to compare
the relative risk of 10 rad (0.1 Gy) to the oocyte or
the preimplanted embryo. If the diagnostic study is
performed in the first 14 days of the menstrual
cycle, the patient should be advised to defer
conception for several months based on the
assumption that the deleterious effect of radiation
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to the ovaries decreases with increasing time
between radiation exposure and a subsequent
ovulation? The physician is in a quandary because
he may be warning the patient about a very-lowrisk phenomenon. On the other hand, avoiding
conception for several months is not an insurmountable hardship. This potential genetic hazard
is quite speculative for man, as indicated by the
NCRP and Biological Effects of Ionizing Radiation
committee report dealing with preconception
radiation1,6:
“It is not known whether the interval between irradiation of the gonads and conception has a marked
effect on the frequency of genetic changes in
human offspring, as has been demonstrated in
the female mouse. Nevertheless, it may be advised
for patients receiving high doses to the gonads (>25
rads) to wait for several months after such exposures before conceiving additional offspring.”3
Because the patients exposed during diagnostic
radiological procedures absorb considerably less
than 25 rad (0.25 Gy), these recommendations
may be unnecessary but they involve no hardship
to the patient. Because both the NCRP and International Commission on Radiological Protection have
previously recommended that elective radiological
examinations of the abdomen and pelvis be performed during the first part of the menstrual cycle
(10-day rule, 14-day cycle) to protect the zygote
from possible but largely conjectural hazards, the
recommendation to avoid fertilization of recently
irradiated ova perhaps merits equal attention.

IMPORTANCE OF DETERMINING PREGNANCY
STATUS OF PATIENTS
If exposures less than 10 rad (0.1 Gy) do not
measurably affect the exposed embryos and if it
is recommended that diagnostic procedures
should be performed at any time during the
menstrual cycle, if necessary, for the medical
care of the patient, then the question of expending
energy to determine the pregnancy status of the
patient arises.
There are several reasons why the physician and
patient should share the burden of determining the
pregnancy status before performing a radiological
or nuclear medicine procedure that exposes the
uterus:
1. If the physician is forced to include the possibility of pregnancy in the differential diagnosis,
a small percentage of diagnostic studies may
no longer be considered necessary. Early
symptoms of pregnancy may mimic certain
types of gastrointestinal or genitourinary
disease.

2. If the physician and patient are both aware that
pregnancy is a possibility and the procedure is
still performed, it is much less likely that the
patient will be upset if she subsequently proves
to be pregnant.
3. The careful evaluation of the reproductive
status of women undergoing diagnostic procedures prevents many unnecessary lawsuits.
Many lawsuits are stimulated by the factor of
surprise. In some instances, the jury is not concerned with cause and effect but with the fact
that something was not done properly by the
physicians.18,19 In this day and age, failure to
communicate adequately can be interpreted
as less-than-adequate medical care. Both
these factors are eliminated if the patient’s
pregnancy status has been evaluated properly
and the situation discussed adequately with
the patient. Physicians should learn that practicing good technical medicine may not be
good enough in a litigation-prone society.
Even more important, the patient will have
more confidence if the decision to continue
the pregnancy is made before the radiological
procedure is performed, because the necessity
of performing the procedure would have been
determined with the knowledge that the patient
was pregnant. In every consultation dealing
with the exposure of the embryo to diagnostic
studies involving ionizing radiation (radiography, computed tomography, use of radionuclides) in which the reproductive risks or
developmental risks for a fetus have not been
increased by the radiation exposure, the patient
should be informed that every healthy woman
with a negative personal and genetic family
reproductive history has background reproductive risks, which are 3% for birth defects and
15% for miscarriage. These background risks
cannot be changed.
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